Last reviewed: June 16, 2026

Last updated: June 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Finding the right therapeutic dose of semaglutide is central to achieving meaningful weight loss while minimizing side effects. Clinical trials show that doses between 1.0 and 2.4 mg weekly produce the most consistent results, though your personal therapeutic window depends on body composition, metabolism, and genetic response patterns. PlexusDx compounded semaglutide injections start at $149 monthly and include personalized dosing support to help you navigate this critical pathway.

Understanding Therapeutic Dose vs. Starting Dose

The starting dose of semaglutide—typically 0.25 mg weekly—is intentionally low to allow your body time to adapt. This initial phase usually lasts 4 weeks and focuses on tolerability rather than maximum effect. Your therapeutic dose arrives later in the titration schedule, usually between weeks 8 and 16, once your system has acclimated to the medication's mechanism. Therapeutic dosing is when semaglutide's full weight-loss and appetite-suppressing effects become apparent.

Most patients find their therapeutic window somewhere between 1.0 and 2.4 mg weekly, though this range varies significantly based on individual factors. Some people achieve excellent results at 1.0 mg, while others require the full 2.4 mg dose for optimal effect. The goal isn't to reach the highest dose; it's to find the dose that produces your best clinical outcome with side effects you can manage long-term.

How Semaglutide Titration Protocols Work

Titration is the gradual increase of your dose over time, designed to let your body adapt while minimizing nausea and gastrointestinal discomfort. A standard 16-week protocol increases your dose by 0.25 mg each week until you reach your therapeutic target. During this phase, PlexusDx providers monitor how you're responding through check-ins and adjust the schedule if needed—some patients benefit from staying at intermediate doses longer before advancing. This personalized pacing reduces dropout rates and improves long-term adherence.

Your therapeutic dose isn't determined by body weight or BMI alone; it's based on your actual response to the medication. Some patients at higher body weights respond beautifully at 1.0 mg, while others need higher doses regardless of starting weight. Plateau phases—where you stay at the same dose for multiple weeks—give your body time to stabilize and let you assess whether you need to advance further or maintain at your current therapeutic level.

Clinical Evidence on Semaglutide Therapeutic Dosing

The SUSTAIN 4 and SUSTAIN 5 trials demonstrated that semaglutide doses of 1.0 mg and higher produced average weight losses of 8–10% of body weight over 30 weeks, with the 2.4 mg dose achieving approximately 13% weight loss. These therapeutic-dose results represent meaningful clinical change for most patients—enough to improve blood pressure, reduce joint stress, and shift metabolic markers. However, these trials also showed significant individual variability, meaning your therapeutic response may differ from these averages.

Therapeutic efficacy peaks at different doses for different people, and the relationship isn't always linear. Some patients plateau at 1.0 mg and see no additional benefit from climbing to 2.4 mg, while others need the full dose to achieve their goals. Real-world data from compounding pharmacies shows that patients guided toward their personal therapeutic sweet spot maintain better adherence and report higher satisfaction than those simply following a standard protocol.

Personalized Dosing at PlexusDx

PlexusDx compounded semaglutide injections begin at $149 per month—a flat rate that never increases based on your dose. Whether your therapeutic dose lands at 0.5 mg, 1.5 mg, or 2.4 mg weekly, your monthly investment stays the same. This transparent pricing structure removes the financial pressure to limit dose escalation or rush through titration, allowing you and your provider to focus purely on clinical outcomes. Medications are prepared by licensed 503A compounding pharmacies and ship directly to your door with no insurance required.

PlexusDx also offers the Precision Peptide Genetic Test ($99 add-on after your first month) to identify genetic variants that influence how your body responds to GLP-1 therapy. This test maps 14 peptide pathways and 49 individual peptides, revealing whether you carry variants in genes like GLP1R rs6923761 or GIPR rs1800437 that may predict stronger or weaker response. Understanding your genetic peptide profile helps PlexusDx providers anticipate whether you'll thrive at lower or higher therapeutic doses and optimize your treatment plan before side effects become limiting.

Managing Side Effects at Your Therapeutic Dose

Nausea, constipation, and appetite loss intensify as your dose increases toward the therapeutic range. These effects typically peak 2–3 days after injection and diminish by day 5 or 6 in most patients. Managing side effects at therapeutic doses involves dietary strategies—eating smaller, protein-rich meals and staying well-hydrated—and sometimes temporary dose-hold periods to let your tolerance catch up. Most patients find that staying at their therapeutic dose for 2–4 weeks before advancing allows GI side effects to settle considerably.

Importantly, mild-to-moderate side effects at therapeutic doses don't necessarily signal a problem; they often reflect the medication's intended mechanism (reduced appetite). The goal is to reach a therapeutic dose where weight loss is meaningful and side effects are tolerable enough to sustain long-term. If a particular dose triggers severe nausea or vomiting, PlexusDx providers can pause advancement, hold at a lower therapeutic level, or explore alternative compounds like oral semaglutide or compounded tirzepatide, which some patients tolerate differently.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the most common therapeutic dose of semaglutide?

Most patients achieve their therapeutic dose between 1.0 and 1.5 mg weekly, though the range extends from 0.5 to 2.4 mg depending on individual response. PlexusDx providers work with you across your titration schedule to identify where your weight loss and side-effect tolerance intersect, rather than targeting a single universal dose.

How long does it take to reach a therapeutic dose?

Standard titration protocols take 16 weeks to reach the 2.4 mg dose, advancing 0.25 mg each week. However, many patients find their therapeutic dose—and their best clinical outcome—at 8–12 weeks and never need to escalate further. PlexusDx allows flexible pacing so you can spend extra time at intermediate doses if needed.

Can I stay on a lower dose if it's working for me?

Absolutely. If you achieve your weight-loss goals and feel well at 1.0 mg or 1.5 mg, there's no clinical reason to advance higher. PlexusDx pricing is flat regardless of dose, so your cost remains $149 per month whether your therapeutic dose is 0.5 mg or 2.4 mg weekly.

What happens if I don't reach the full 2.4 mg dose?

Not reaching the maximum dose is completely normal and often clinically appropriate. Your therapeutic dose is the dose that produces your best outcome, not necessarily the highest dose available. Many successful long-term patients maintain at 1.0–1.5 mg because that's where their personal therapeutic window sits.

How does the PlexusDx Precision Peptide Genetic Test help predict my therapeutic dose?

The Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence how strongly you'll respond to semaglutide. Certain genetic profiles predict a stronger response to lower doses, while others suggest you may need higher therapeutic doses to see meaningful results. This personalized insight helps PlexusDx providers anticipate your likely therapeutic window and optimize titration pacing.

Is compounded semaglutide as effective as brand-name Ozempic?

Compounded semaglutide from licensed 503A pharmacies contains the same active ingredient as brand-name versions and follows identical manufacturing standards. The primary difference is cost—PlexusDx compounded semaglutide starts at $149 monthly with no insurance required, making therapeutic dosing accessible to far more patients.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves